Jubilant Organosys is to purchase Draxis Health for $225m. Jubilant said the deal gives it "an entry into the attractive, regulated, high growth and high margin radiopharmaceutical business".
Reuters
Saturday 5 April 2008
Jubilant buys Draxis
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment